access to medicines

access to medicines

21. Slower drug approval times do not improve patient safety

22. Recognizing the negative impacts of pricing and reimbursement delays, Europe pursues measures to boost pharmaceutical innovation for the benefit of patients

23. Canadians patients wait longer than patients in other countries for access to new drugs because of lengthy approval times

24. Formulary restrictions on antidepressant medications undermine the effective management of depression and related disorders

25. Incremental advances in pharmaceuticals provide the elderly with more treatment options and improved health outcomes

26. Mail-order internet pharmacies in Canada cannot meet the needs of American consumers and may cause shortages for Canadian patients

27. Few new medicines are available to those who depend on provincial drug benefit programs

28. Preferred drug lists are a barrier to ensuring that patients get the treatments they need

29. States may save $ billions if a prescription drug benefit is added to Medicare

<< Start < Prev 1 2 3 Next > End >>

Powered by Tags for Joomla

Top Topics

Latest News

Popular Articles

Social Media

Login

Who's Online

We have 153 guests online

Latest Events

No events